Page 172 - Read Online

Page 10 of 10 Komatsu et al. J Cancer Metastasis Treat 2018;4:36 I http://dx.doi.org/10.20517/2394-4722.2017.58

74. Yang R, Fu Y, Zeng Y, Xiang M, Yin Y, Li L, Xu H, Zhong J, Zeng X. Serum miR-20a is a promising biomarker for gastric cancer.
Biomed Rep 2017;6:429-34.
75. Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF, Li N, Tang B, Liu KY, Xiao B. Plasma microRNAs,
miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 2012;7:e41629.
76. Wang B, Zhang Q. The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin
Oncol 2012;138:1659-66.
77. Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, Kusunoki H, Inoue K, Uedo N, Iishi H, Haruma K. Identification of serum
miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer 2013;109:2323-30.
78. Song J, Bai Z, Zhang J, Meng H, Cai J, Deng W, Bi J, Ma X, Zhang Z. Serum microRNA-21 levels are related to tumor size in gastric
cancer patients but cannot predict prognosis. Oncol Lett 2013;6:1733-7.
79. Huang S, Wang J, Li J, Luo Q, Zhao M, Zheng L, Dong X, Chen C, Che Y, Liu P, Qi J, Huang C. Serum microRNA expression profile as
a diagnostic panel for gastric cancer. Jpn J Clin Oncol 2016;46:811-8.
80. Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P. Evaluation of serum microRNA biomarkers for gastric cancer
based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br J Cancer 2017;117:266-73.
81. Zhuang K, Han K, Tang H, Yin X, Zhang J, Zhang X, Zhang L. Up-regulation of plasma miR-23b is associated with poor prognosis of
gastric cancer. Med Sci Monit 2016;22:356-61.
82. Zhang R, Wang W, Li F, Zhang H, Liu J. MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers.
Med Oncol 2014;31:243.
83. Li F, Guo Y, Liu J, Zhang R. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer. PLoS One
2017;12:e0178427.
84. Ayremlou N, Mozdarani H, Mowla SJ, Delavari A. Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation
with tumor hypoxia. Cancer Biomark 2015;15:851-60.
85. Cui MH, Hou XL, Lei XY, Mu FH, Yang GB, Yue L, Fu Y, Yi GX. Upregulation of microRNA 181c expression in gastric cancer tissues
and plasma. Asian Pac J Cancer Prev 2013;14:3063-6.
86. Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci
2014;15:4031-48.
87. Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, Zhu ZG. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
Ann Surg Oncol 2013;20 Suppl 3:S397-405.
88. Zhang HP, Sun FB, Li SJ. Serum miR-200c expression level as a prognostic biomarker for gastric cancer. Genet Mol Res 2015;14:15913-
20.
89. Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW. Overexpression of miR-370 and downregulation
of its novel target TGFbeta-RII contribute to the progression of gastric carcinoma. Oncogene 2012;31:226-37.
90. Song J, Yin J, Bai Z, Zhang J, Meng H, Cai J, Deng W, Ma X, Zhang Z. The profile of serum microRNAs predicts prognosis for resected
gastric cancer patients receiving platinum-based chemotherapy. Dig Dis Sci 2017;62:1223-34.
91. Zeng Q, Jin C, Chen W, Xia F, Wang Q, Fan F, Du J, Guo Y, Lin C, Yang K, Li J, Peng X, Li X, Cao K. Downregulation of serum miR-
17 and miR-106b levels in gastric cancer and benign gastric diseases. Chin J Cancer Res 2014;26:711-6.
92. Qiu X, Zhang J, Shi W, Liu S, Kang M, Chu H, Wu D, Tong N, Gong W, Tao G, Zhao Q, Qiang F, Zhu H, Wu Q, Wang M, Zhang Z.
Circulating microRNA-26a in plasma and its potential diagnostic value in gastric cancer. PLoS One 2016;11:e0151345.
93. Shen YH, Xie ZB, Yue AM, Wei QD, Zhao HF, Yin HD, Mai W, Zhong XG, Huang SR. Expression level of microRNA-195 in the
serum of patients with gastric cancer and its relationship with the clinicopathological staging of the cancer. Eur Rev Med Pharmacol Sci
2016;20:1283-7.
94. Gorur A, Balci Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS, Tamer L. Determination of
plasma microRNA for early detection of gastric cancer. Mol Biol Rep 2013;40:2091-6.
95. Chen X, Liu XS, Liu HY, Lu YY, Li Y. Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer. Genet Mol Res
2016;15.
96. Hou CG, Luo XY, Li G. Diagnostic and prognostic value of serum microRNA-206 in patients with gastric cancer. Cell Physiol Biochem
2016, 39:1512-20.
97. Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL, Yao GL. Reduced expression of circulating microRNA-218 in gastric cancer and correlation
with tumor invasion and prognosis. World J Gastroenterol 2014;20:6906-11.
98. Zhang WH, Gui JH, Wang CZ, Chang Q, Xu SP, Cai CH, Li YN, Tian YP, Yan L, Wu B. The identification of miR-375 as a potential
biomarker in distal gastric adenocarcinoma. Oncol Res 2012;20:139-47.
99. Wu D, Cao G, Huang Z, Jin K, Hu H, Yu J, Zeng Y. Decreased miR-503 expression in gastric cancer is inversely correlated with serum
carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker. Onco Targets Ther 2017;10:129-35.
100. Wang WN, Chen Y, Zhang YD, Hu TH. The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and
progression of gastric cancer. Tumour Biol 2013;34:1865-71.
101. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO
Mol Med 2012;4:143-59.